Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    Segment length and risk for neoplastic progression in patients with Barrett esophagus.

    El-Serag HB.

    Ann Intern Med. 2000 Nov 7;133(9):747-8. No abstract available. PMID: 11074916 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group.

    Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus HW.

    Cancer. 1993 Aug 15;72(4):1155-8.PMID: 8339208 [PubMed - indexed for MEDLINE]Related articles

    3.

    Should we worry about the length of Barrett's esophagus?

    Shaheen NJ.

    Gastrointest Endosc. 2005 Nov;62(5):682-5. No abstract available. PMID: 16246679 [PubMed - indexed for MEDLINE]Related articles

    4.

    Risk factors, DNA damage, and disease progression in Barrett's esophagus.

    Olliver JR, Hardie LJ, Gong Y, Dexter S, Chalmers D, Harris KM, Wild CP.

    Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):620-5.PMID: 15767340 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.

    Chang JT, Katzka DA.

    Arch Intern Med. 2004 Jul 26;164(14):1482-8. Review.PMID: 15277277 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Risk factors for neoplastic progression in Barrett's mucosa.

    Menke-Pluymers MB.

    Eur J Surg Oncol. 1996 Aug;22(4):311-6. Review. No abstract available. PMID: 8783642 [PubMed - indexed for MEDLINE]Related articles

    7.

    Is short segment Barrett's clinically significant?

    Maniatis AG, Brazer SR.

    Am J Gastroenterol. 1995 Oct;90(10):1894-5. No abstract available. PMID: 7572923 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Barrett esophagus: epidemiology and natural history of tumor progression]

    Cauvin JM.

    Gastroenterol Clin Biol. 1999 Jun;23(5 Pt 2):B12-9. Review. French. No abstract available. PMID: 10897769 [PubMed - indexed for MEDLINE]Related articles

    9.

    Barrett's oesophagus--50 years on.

    Maric R, Cheng KK.

    Br J Surg. 2000 Nov;87(11):1594. No abstract available. PMID: 11091252 [PubMed - indexed for MEDLINE]Related articles

    10.

    Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.

    Shaheen N, Ransohoff DF.

    JAMA. 2002 Apr 17;287(15):1972-81. Review.PMID: 11960540 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [From Barrett esophagus to adenocarcinoma: can the dangers of natural history be overcome?]

    Robaszkiewicz M.

    Gastroenterol Clin Biol. 1996;20(5 Pt 2):B89-97. Review. French. No abstract available. PMID: 8761127 [PubMed - indexed for MEDLINE]Related articles

    12.

    Neoplastic risk assessment in Barrett's esophagus: How far have we come?

    Noffsinger A.

    Hum Pathol. 2003 Oct;34(10):965-7. Review. No abstract available. PMID: 14608528 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Barrett esophagus: features of structure and diagnostic tactics]

    Gomoliako IV, Bogomolets VV, Klochkova NE.

    Klin Khir. 1996;(5):46-9. Review. Russian. No abstract available. PMID: 8991687 [PubMed - indexed for MEDLINE]Related articles

    14.

    Management of Barrett's esophagus: cases and questions.

    Bresalier R.

    Semin Oncol. 2005 Dec;32(6 Suppl 9):S2-5.PMID: 16399421 [PubMed - indexed for MEDLINE]Related articles

    15.

    Disputing dysplasia.

    Spechler SJ.

    Gastroenterology. 2001 Jun;120(7):1864-8. No abstract available. PMID: 11375967 [PubMed - indexed for MEDLINE]Related articles

    16.

    Diagnosing and managing Barrett's esophagus.

    Sampliner RE.

    Am J Manag Care. 2000 Oct;6(16 Suppl):S886-90. Review.PMID: 11184660 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus.

    Kristal AR, Blount PL, Schenk JM, Sanchez CA, Rabinovitch PS, Odze RD, Standley J, Vaughan TL, Reid BJ.

    Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2377-83.PMID: 16214920 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

    Rudolph RE, Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipeau PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BJ.

    J Natl Cancer Inst. 2003 May 21;95(10):750-7.PMID: 12759393 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Gastroesophageal reflux and adenocarcinoma of the esophagus.

    Heath EI, Holbrook JT, Forastiere AA.

    N Engl J Med. 1999 Aug 12;341(7):536-7; author reply 537-8. No abstract available. PMID: 10447438 [PubMed - indexed for MEDLINE]Related articles

    20.

    DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues.

    Fang M, Lew E, Klein M, Sebo T, Su Y, Goyal R.

    Am J Gastroenterol. 2004 Oct;99(10):1887-94.PMID: 15447746 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data